Evidence map›Paper›PMID 35752942›Full record

ArticleProteins2022

Activation of p53: How phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ.

Sonia T Nicolaou, Srinivasaraghavan Kannan, Jim Warwicker, Chandra S Verma

Open access · hybridAbstract read
In one paragraph

Article in Proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Sonia T NicolaouFaculty of Biology, Medicine and Health, School of Biological Sciences, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.ORCID 0000-0001-6849-6872
Srinivasaraghavan KannanBioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.ORCID 0000-0002-9539-5249
Jim WarwickerFaculty of Biology, Medicine and Health, School of Biological Sciences, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.ORCID 0000-0002-1302-0815
Chandra S VermaBioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.ORCID 0000-0003-0733-9798
Agency for Science, Technology and Research · SGManchester Academic Health Science Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The N-terminal transactivation domain (TAD) of p53 is a disordered region with multiple phosphorylation sites. Phosphorylation at Thr18 is crucial for the release of p53 from its negative regulator, MDM2. In stressed cells, CK1δ is responsible for phosphorylating Thr18, but requires Ser15 to be phosphorylated. To understand the mechanistic underpinnings of this sequential phosphorylation, molecular modeling and molecular dynamics simulation studies of these phosphorylation events were carried out. Our models suggest that a positively charged region on CK1δ near the adenosine triphosphate (ATP) binding pocket, which is conserved across species, sequesters the negatively charged pSer15, thereby constraining the positioning of the rest of the peptide, such that the side chain of Thr18 is positioned close to the γ-phosphate of ATP. Furthermore, our studies show that the phosphorylated p53 TAD1 (p53pSer15) peptide binds more strongly to CK1δ than does p53. p53 adopts a helical structure when bound to CK1δ, which is lost upon phosphorylation at Ser15, thus gaining higher flexibility and ability to morph into the binding site. We propose that upon phosphorylation at Ser15 the p53 TAD1 peptide binds to CK1δ through an electrostatically driven induced fit mechanism resulting in a flanking fuzzy complex.

Indexed as

Molecular Dynamics SimulationTumor Suppressor Protein p53Adenosine TriphosphateBinding SitesPhosphorylationAdenosine TriphosphateTumor Suppressor Protein p53fuzzy complexintrinsically disordered proteinsmolecular dynamicsp53phosphorylation

Identifiers

PMID35752942
PMCPMC9796392
OpenAlexW4283511748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.